Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
CorrectionCorrection

Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024

Andre L. Ribeiro, Tommy Kok Annfeldt, Dafna D. Gladman, William Tillett, Ana-Maria Orbai and Ying Ying Leung
The Journal of Rheumatology August 2025, jrheum.2025-0268.C1; DOI: https://doi.org/10.3899/jrheum.2025-0268.C1
Andre L. Ribeiro
A.L. Ribeiro, MD, MSc, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andre L. Ribeiro
Tommy Kok Annfeldt
T.K. Annfeldt, MSc Pharm, Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tommy Kok Annfeldt
Dafna D. Gladman
D.D. Gladman, MD, University of Toronto, Schroeder Arthritis Institute, Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dafna D. Gladman
William Tillett
W. Tillet, MB ChB, PhD, Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for William Tillett
Ana-Maria Orbai
A.M. Orbai, MD, MHS, Psoriatic Arthritis Program, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ana-Maria Orbai
Ying Ying Leung
Y.Y. Leung, MB ChB, MD, Duke-NUS Medical School, Department of Rheumatology and Immunology, Singapore General Hospital, Singapore.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ying Ying Leung
  • Article
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Abstract

J Rheumatol 2025; doi: 10.3899/jrheum.2025-0268

The affiliation for Tommy Kok Annfeldt should be Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark. This correction applies only to the August 5 First Release. The correct affiliation appears in the print and online issues.

doi: 10.3899/jrheum.2025-0268.C1

PreviousNext
Back to top

In this issue

The Journal of Rheumatology: 52 (11)
The Journal of Rheumatology
Vol. 52, Issue 11
1 Nov 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024
Andre L. Ribeiro, Tommy Kok Annfeldt, Dafna D. Gladman, William Tillett, Ana-Maria Orbai, Ying Ying Leung
The Journal of Rheumatology Aug 2025, jrheum.2025-0268.C1; DOI: 10.3899/jrheum.2025-0268.C1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024
Andre L. Ribeiro, Tommy Kok Annfeldt, Dafna D. Gladman, William Tillett, Ana-Maria Orbai, Ying Ying Leung
The Journal of Rheumatology Aug 2025, jrheum.2025-0268.C1; DOI: 10.3899/jrheum.2025-0268.C1
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study
  • Priority Setting of Physical Activity Barriers and Facilitators Among Individuals With Rheumatoid Arthritis: A Nominal Group Technique Study
Show more Correction

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire